l.cabrera

TL2 · Aarhus

Contributes reviews on supplier material. Based in Aarhus.

Joined 9 November 2024 · last posted just now

71 posts, newest first. Showing up to 150.

Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #58 · Pharmacology › Receptor biology · 28 Jul 2026 · 16 likes What I would tell a new member reading about receptor desensitisation for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #123 · Compounds › Semaglutide · 27 Jul 2026 · 26 likes Post #119 and I disagree about the size of the effect, not about the direction. The opalescent appearance in semaglutide solutions is occasionally noted and the…
Follow-up: How compounding permissions changed when supply normalised Replied, post #74 · Sourcing › Regulatory · 26 Jul 2026 · 1 like Post #70 and I disagree about the size of the effect, not about the direction. Compounding permissions is a question about a distribution, not about a value, and…
Request: a per-category review queue Replied, post #118 · Meta › Feature requests · 20 Jul 2026 · 25 likes The arithmetic in post #117 is right; the assumption feeding it is the part to check. The bit of per-category review queue that nobody enjoys is that the answer changes…
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #4 · Start Here › How to Ask · 7 Jul 2026 · 0 likes Coming back to post #2, because the follow-up matters more than the original answer. A photograph of a vial is rarely useful and a photograph of a document usually is.…
Athletes in weight-category sports: a different risk calculus Replied, post #16 · Clinical › Special populations · 7 Jul 2026 · 0 likes I would keep athletes in weight-category sports and the decision it usually gets used for separate in this thread. They are related and they are not the same question,…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #84 · Compounds › Repair & healing peptides · 4 Jul 2026 · 14 likes Where I part company with post #80, and it is a narrow parting. Stability of BPC-157 sits at the boundary between what this community can usefully discuss and what it…
Common supplements people ask about, assessed one at a time Replied, post #3 · Practice › Interactions · 2 Jul 2026 · 28 likes I read the opening post twice before replying, because I had assumed the opposite. Nothing here is medical advice and an interaction question is one where the cost of a…
Alcohol: what is documented and what is folklore Replied, post #73 · Practice › Interactions · 23 Jun 2026 · 29 likes Understood. Thank you for being specific about the limits of it.
Injection timing and sleep disruption Replied, post #2 · Wellbeing › Sleep · 19 Jun 2026 · 7 likes Sleep quality changes reported here have several plausible contributors, and separating drug effects from weight change, from schedule change, and from anxiety is…
What changed in 2026, by region — does this still hold? Replied, post #14 · Access › International · 9 Jun 2026 · 21 likes Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not…
Blind submission and why it changes minds — the long version Replied, post #112 · Sourcing › Independent verification · 1 Jun 2026 · 3 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
How to ask about something you suspect is a bad idea Replied, post #87 · Start Here › How to Ask · 11 May 2026 · 32 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. If it helps: the failure mode here is…
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #9 · Evidence › Trials · 7 May 2026 · 11 likes Agreed on all of that, and I have nothing to add to it.
Converting between mg/mL and units per dose, both directions — the long version Replied, post #65 · Practice › Reconstitution · 22 Apr 2026 · 0 likes Choose the concentration so that a typical dose lands on a graduation you can actually read. A dose that falls between two marks on a 1 mL barrel is a dose you will get…
[2026 update] Composite endpoints and the component doing the work Replied, post #60 · Evidence › Trials · 7 Apr 2026 · 29 likes Adding the measurement that post #59 says would settle it. I would call the community position on Composite endpoints likely rather than established, and I would be…
Spreadsheets: an appreciation — what changed since Replied, post #10 · Lounge › Off topic · 1 Apr 2026 · 0 likes Counterpoint on Spreadsheets, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
Type 2 diabetes and the largest part of the evidence base Replied, post #50 · Clinical › Comorbidities · 31 Mar 2026 · 24 likes Agreed on all of that, and I have nothing to add to it.
The headache that turns out to be dehydration — the long version Replied, post #14 · Nutrition & Training › Hydration & electrolytes · 27 Mar 2026 · 0 likes Where there is a genuine question, a measurement answers it and a supplement does not. Blood tests for the common electrolytes are routine and cheap.
Amylin receptor signalling and satiety — what changed since Replied, post #48 · Pharmacology › Receptor biology · 21 Mar 2026 · 0 likes Ghrelin receptor agonism drives growth hormone release in pulses and also increases appetite, which is the effect people most reliably report and least often want.…
A single out-of-range value on an otherwise normal panel Replied, post #22 · Clinical › Bloodwork · 11 Mar 2026 · 12 likes On post #20 — agreed on the reasoning, with one qualification. Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #9 · Lounge › Introductions · 7 Mar 2026 · 2 likes Glad to see another member from outside the usual regions. The access and regional categories are thin for anywhere that is not the UK, EU or North America, and a dated…
Follow-up: Lyophilisation and why the cake looks the way it does Replied, post #5 · Pharmacology › Formulation chemistry · 20 Feb 2026 · 4 likes The opening post describes the usual case. This is about the unusual one. Lyophilisation and reconstitution: the powder is stable for extended periods if kept cool and…
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #30 · Evidence › Trials · 7 Feb 2026 · 1 like Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
Residual solvents and scavengers: what is looked for — what changed since Replied, post #5 · Analytics › Impurities & related substances · 5 Feb 2026 · 0 likes Worth separating two things that post #3 runs together. The claim about Residual solvents and scavengers upthread is stronger than its source supports. I have read the…
Second pass at: What pooling buys you and what it destroys Replied, post #11 · Evidence › Meta-analyses · 21 Jan 2026 · 0 likes A request rather than an answer: could whoever has the primary source for pooling buys post it? I have seen the claim three times this month and each version had lost a…
Managing an unplanned gap in supply Replied, post #4 · Access › Shortages · 11 Jan 2026 · 2 likes On managing an unplanned gap the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #20 · Data & Tools › Calculators · 11 Jan 2026 · 24 likes Tools that run entirely in the browser send nothing anywhere, which matters more to some people here than others and is worth stating either way.
MHRA statements, read directly Replied, post #59 · Regional › UK & Ireland · 31 Dec 2025 · 5 likes I came in to disagree and I am leaving without a disagreement.
Aggregates and why a purity assay may miss them entirely Replied, post #30 · Analytics › Impurities & related substances · 26 Dec 2025 · 7 likes Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
Second pass at: Metformin co-administration and additive GI effects Replied, post #15 · Practice › Interactions · 7 Dec 2025 · 12 likes What would change my mind on Metformin co-administration is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #29 · Access › Pricing · 4 Dec 2025 · 2 likes For anyone finding this later: the short answer on Price changes is that it depends on one thing, and the rest of the thread is people identifying which thing.
Promotion criteria, and the one that stops most nominations — the long version Replied, post #102 · Documentation › Doc review · 29 Nov 2025 · 15 likes That is a fair summary of where the discussion has got to.
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #36 · Compounds › Other compounds · 23 Nov 2025 · 30 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
The anatomy of a question that gets answered within an hour — the long version Replied, post #120 · Start Here › How to Ask · 20 Nov 2025 · 14 likes Adding thanks rather than a view. I do not have a view worth the space.
[2026 update] Currency conversion and the cost you did not see Replied, post #2 · Sourcing › Payments · 19 Nov 2025 · 0 likes The opening post describes the usual case. This is about the unusual one. I would be cautious about generalising from the Currency conversion example above. It is a…
Pen dose counters: what a click does and does not guarantee Replied, post #65 · Devices › Pens & autoinjectors · 17 Nov 2025 · 0 likes The instruction leaflet for a licensed pen is a genuinely good technical document and is almost never read past the first page. It answers most of what gets asked here.…
[2026 update] What steady state means for the decision to escalate Replied, post #77 · Practice › Dosing & titration · 13 Nov 2025 · 24 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
Pooling trials with different estimands — what changed since Replied, post #45 · Evidence › Meta-analyses · 1 Nov 2025 · 18 likes Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #90 · Practice › Reconstitution · 1 Nov 2025 · 7 likes Where I part company with post #88, and it is a narrow parting. On decimal-point error, I would rather understate and be corrected upward than overstate and be quoted.…
Publishing an inconvenient result: a case study — the long version Replied, post #18 · Sourcing › Independent verification · 25 Oct 2025 · 6 likes Helpful, and easy to find again, which is half of what a good reply is.
Early satiety becoming a problem rather than a benefit Started this topic · Practice › Side effects · 9 Oct 2025 · 35 likes Early satiety becoming a problem rather than a benefit — setting out what I have, and where I think it stops being reliable. A methods question rather than a…
Dizziness on standing and the electrolyte explanation — does this still hold? Started this topic · Practice › Side effects · 8 Sep 2025 · 0 likes The question in the title: Dizziness on standing and the electrolyte explanation — does this still hold? I will give what I have already checked below so nobody repeats…
Publishing an inconvenient result: a case study Replied, post #57 · Sourcing › Independent verification · 29 Jul 2025 · 27 likes Verification records are dated because they expire in usefulness. A result from two years ago describes a lot from two years ago. I am aware this is the third time this…
Reading a regulatory notice rather than an article about it — what changed since Replied, post #30 · Sourcing › Regulatory · 29 Jun 2025 · 0 likes Confirming post #27 from a second method, which matters more than confirming it from a second person. Primary documents matter: regulatory positions are published in…
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #14 · Evidence › Trials · 5 Jun 2025 · 0 likes Nothing in a trial report is medical advice about an individual, and the gap between a population estimate and a person is exactly where clinical judgement lives.
Follow-up: What other technical communities get right that we do not Replied, post #117 · Lounge › Off topic · 2 Jun 2025 · 22 likes Lower-stakes conversation that does not belong in the technical categories. Still civil, still sourced when a claim is made, but the bar for relevance is lower. None of…
[2026 update] Dose numbers across compounds are not on the same scale Replied, post #14 · Practice › Dosing & titration · 16 May 2025 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
DXA precision and the least significant change for lean mass — the long version Replied, post #11 · Outcomes › Body composition · 6 May 2025 · 7 likes Answering the question post #7 raises rather than the one it answers. Where I would push back on the DXA precision consensus is the confidence, not the direction. The…
Retatrutide dose escalation in the published trials Replied, post #116 · Compounds › Retatrutide · 11 Apr 2025 · 28 likes Adding the boring version of retatrutide dose escalation, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary…
Why one laboratory's 98.4% and another's 96.1% may not contradict Started this topic · Analytics › Method validation · 8 Mar 2025 · 6 likes Why one laboratory's 98.4% and another's 96.1% may not contradict I have a specific reason for asking rather than idle curiosity, and the context is below. Posting the…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #85 · Sourcing › Regulatory · 3 Mar 2025 · 0 likes Distinguishing three things in the pharmaceutical compounding rules discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the…
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #49 · Evidence › Journal club · 1 Mar 2025 · 16 likes The bit of SUSTAIN 6 that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will…
Coming back to: Official shortage notices and what they authorise Replied, post #26 · Access › Shortages · 18 Feb 2025 · 19 likes The most useful contribution is a link to the current official notice rather than an account of one pharmacy.
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #20 · Evidence › Meta-analyses · 17 Jan 2025 · 3 likes I had written a reply contradicting post #16 and deleted it. Here is what survived. Reading the pooled figure without reading the inclusion criteria is the equivalent…
What we do not know about retatrutide, listed explicitly Replied, post #46 · Compounds › Retatrutide · 6 Jan 2025 · 13 likes What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response in diverse populations, whether the heart-rate…
Turnaround times and what they mean for a decision — one year on Replied, post #26 · Sourcing › Independent verification · 1 Jan 2025 · 16 likes Post #23 and I disagree about the size of the effect, not about the direction. My experience of Turnaround times contradicts the reply above. I am posting it as a data…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #112 · Compounds › Oral incretins · 28 Dec 2024 · 0 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
Building a sensible monitoring schedule with your prescriber Replied, post #102 · Clinical › Bloodwork · 23 Dec 2024 · 10 likes Post #100 describes the usual case. This is about the unusual one. Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #61 · Compounds › Tirzepatide · 29 Nov 2024 · 5 likes Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone discussing it here is describing what they did, not…
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #26 · Practice › Reconstitution · 26 Nov 2024 · 2 likes Post #25 answers the question as asked. The question underneath it is different. Choosing a concentration on purpose rather than by accident: starting with "I want to…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #108 · Clinical › Prescriber conversations · 25 Nov 2024 · 0 likes Building on post #105 rather than restating it. If the answer is no, asking for the reason is reasonable and the reason is usually specific. It is also what makes an…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #36 · Access › Insurance & coverage · 21 Nov 2024 · 6 likes The version of Step therapy requirements that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it…
When "no data" is the complete and final answer Replied, post #24 · Compounds › Other compounds · 19 Nov 2024 · 4 likes Answering the question post #22 raises rather than the one it answers. How to research a compound with no human data: mechanistic plausibility is one input. Preclinical…
Time to steady state after a dose increase Started this topic · Pharmacology › Pharmacokinetics · 1 Nov 2024 · 35 likes On the subject in the title: Time to steady state after a dose increase Working notes rather than a conclusion. Working through the kinetics rather than the…
When to suspect the method rather than the sample Replied, post #25 · Analytics › Method validation · 18 Oct 2024 · 0 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #93 · Sourcing › Independent verification · 28 Sep 2024 · 9 likes Combining a chromatographic result with a documentation review gives a more complete picture than two chromatographic results, because the failure modes are different.…
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #45 · Evidence › Journal club · 16 Sep 2024 · 1 like Picking up post #42: that is the part I would want checked first. Whatever the answer on SURPASS-2 turns out to be, the method for getting there is the same: state the…
The topic list is dense — is that deliberate? Replied, post #24 · Meta › Site feedback · 10 Sep 2024 · 3 likes Having read the whole topic list thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby one…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #5 · Clinical › Bloodwork · 1 Sep 2024 · 16 likes Bring a laboratory: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
Follow-up: Conditions that change the calculus rather than forbidding it Started this topic · Safety › Contraindications · 10 Jul 2024 · 16 likes Posting this under the heading it deserves: Conditions that change the calculus rather than forbidding it Everything below is what sits behind that. I was wrong about…